HQL
abrdn Life Sciences Investors
Latest Form 4:Purchase$10KbyMahai Chris LaVictoire (Director) · filed Jul 20, 2026
abrdn Life Sciences Investors (HQL) has 8 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 20, 2026.
The most active filer is 10% Owner Saba Capital Management, L.P. with 9 filings.
- Industry:Asset Management
- CEO:Daniel R. Omstead
- HQ:Philadelphia, PA, US
- IPO:1992-05-01
Insider Buying
$144K
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 527 | $10K | Jul 20 | SEC ↗ | |
Pittard ChristianFirst filing | Director | Purchase | 7,923 | $134K | Dec 18 | SEC ↗ |
| 10% Owner | Sale | 6,989 | $99K | Sep 23 | SEC ↗ | |
| 10% Owner | Sale | 41,623 | $589K | Sep 23 | SEC ↗ | |
| 10% Owner | Sale | 24,328 | $340K | Sep 19 | SEC ↗ | |
| 10% Owner | Sale | 40,208 | $566K | Sep 19 | SEC ↗ | |
| 10% Owner | Sale | 700 | $10K | Sep 17 | SEC ↗ | |
| 10% Owner | Sale | 2,026 | $28K | Sep 17 | SEC ↗ | |
| 10% Owner | Sale | 15,116 | $216K | Sep 15 | SEC ↗ | |
| 10% Owner | Sale | 14,083 | $198K | Sep 4 | SEC ↗ | |
Saba Capital Management, L.P.First filing | 10% Owner | Sale | 23,723 | $330K | Sep 2 | SEC ↗ |